ERBB2 and breast cancer: Tien et al. [29] found that CDK12 promotes the migration and invasion of HER2+ breast cancer by regulating the alternative last exon splicing of the DDR activator ATM (ataxia telangiectasia-mutated) and DNAJB6 (DnaJ homolog subfamily B member 6).